What should I know first?

Stimulant use disorder involves impaired control over stimulant use and significant consequences for health or everyday life. This article covers the clinical grouping that includes cocaine and amphetamine-type stimulants; tobacco and caffeine are classified separately. Cocaine, methamphetamine and prescribed stimulant medicines differ in their properties and medical uses.

Taking a prescribed ADHD medicine as directed does not by itself establish addiction. A useful assessment identifies the actual substance, pattern and consequences rather than attaching a diagnosis to anyone who has used a stimulant.

Signs and Symptoms

Possible signs include repeated unsuccessful attempts to cut down, strong urges, prolonged periods organized around use and continuing despite physical or social harm. Intoxication may involve wakefulness, reduced appetite, agitation or suspiciousness, but symptoms differ by substance and person. After use, fatigue, disrupted sleep, low mood and craving can occur.

Severe chest pain, overheating, seizures, collapse or marked confusion are emergencies. Suicidal thoughts may emerge or intensify as intoxication wears off or during withdrawal. These risks require attention even when the longer-term diagnosis is still uncertain.

How Is It Diagnosed?

Clinicians assess substance identity, frequency, loss of control, consequences, prescribed medicines and the timeline of symptoms. They also consider cardiovascular health, sleep, nutrition and mental health. A drug test can support an exposure history, but detection has limits and does not establish a use disorder on its own.

The diagnosis distinguishes cocaine-related and amphetamine-type presentations where appropriate. Intoxication, withdrawal and substance-induced psychosis are assessed separately from the sustained pattern of use. A supportive conversation and repeated assessment can be more informative than a single encounter.

How Common Is It?

The burden differs substantially by substance, region and reporting period. Figures for any stimulant use should not be mistaken for the prevalence of stimulant use disorder, and cocaine and methamphetamine statistics cannot simply be merged without checking definitions. Treatment and overdose records also capture different aspects of harm.

Current professional guidance describes a serious public health problem, including complications from combined or unexpected opioid exposure. This article avoids a single universal percentage because populations, supply patterns and methods of identifying a disorder differ across studies.

What Causes It?

Risk involves the interaction of repeated exposure, individual vulnerability and circumstances. Stimulants may initially be used for energy, performance, pleasure or relief from distress; the experience can reinforce further use. Sleep loss and stress can make control more difficult. Mental health conditions, unstable living circumstances and limited access to treatment may complicate recovery, without making the disorder inevitable.

Prescribed treatment requires its own careful assessment rather than assumptions about addiction. Clinicians explore what maintains use and what practical changes could reduce harm and support lasting alternatives.

What Do We Know About the Brain?

Stimulants influence brain systems involved in alertness, reward and motivation. Repeated exposure can strengthen the pull of drug-related cues and disrupt sleep, mood and decision-making. When effects wear off, fatigue and reduced enjoyment can make returning to use tempting. These mechanisms help explain difficulties with control but do not define a person's character or determine their future.

Research findings are not a diagnostic brain test. Supporting sleep, physical health and meaningful everyday activities is part of recovery alongside interventions directed at substance use.

Conditions With Similar Symptoms

Mania, anxiety, ADHD, primary psychotic disorders and medical conditions can share features with stimulant intoxication or withdrawal. Sleep deprivation alone can worsen thinking and perception. The sequence of use and symptoms, previous episodes without substances and follow-up help distinguish these conditions.

A positive stimulant test does not exclude an independent disorder. Likewise, prescribed stimulant treatment is not automatically the explanation for new symptoms. Chest pain, seizures, severe agitation or delirium need immediate medical evaluation rather than being attributed only to a psychiatric diagnosis.

Other Conditions That Can Occur Together

Depression, anxiety, ADHD, trauma-related problems and other substance use disorders may coexist. Clinicians also assess cardiovascular complications and other physical health needs relevant to the person's exposure and circumstances. Opioid exposure may be intentional or unexpected, making overdose prevention important.

The presence of another disorder is not a reason to deny stimulant-use treatment. Plans should coordinate care, clarify which symptoms persist outside intoxication and provide appropriate support during periods of low mood or impaired judgment. Family or trusted supporters can contribute with the person's agreement.

Treatment and Support

Contingency management has the strongest established support in the ASAM/AAAP guideline. It uses structured, agreed rewards for treatment goals, rather than punishment, and can be combined with cognitive behavioral therapy or community reinforcement approaches. Treatment also addresses medical complications, housing, relationships and access barriers.

Acute intoxication may need emergency or hospital care; withdrawal support should include assessment of mood and suicide risk. Overdose education and naloxone access are relevant when opioid exposure is possible. Care should remain respectful and individualized even when use continues.

For adolescents, use a program designed for young people or adapted to their development. This may combine rewards for agreed recovery goals, coping skills, and family work. Group treatment should use peers of a similar age when possible. Off-label medication decisions require individual specialist assessment of benefits, risks, and developmental context.

Can Medication Help?

FDA identifies no approved medication specifically for stimulant use disorder, while the ASAM/AAAP guideline discusses selected off-label options. Off-label means a use is not the medication's approved indication; it does not mean that every option is equally supported or suitable.

Specialist decisions depend on the stimulant involved, coexisting conditions and monitoring needs. Medicines may also treat acute complications or an independent psychiatric condition. They do not replace behavioral care, and this article does not provide a regimen. Prescribed ADHD treatment should be reviewed individually rather than stopped automatically.

What to Expect Over Time

Recovery is possible, but the pace varies. Sleep, energy, concentration and mood may need continuing attention after stopping or reducing use. Persistent symptoms should be assessed rather than assumed to be permanent brain damage or simply ignored as withdrawal. Return to use can indicate that the support plan needs adjustment.

Continued contact can help detect cardiovascular or psychiatric complications and maintain progress in everyday functioning. A clinician should reassess risk during transitions and periods of severe depression, not only when stimulant use is at its highest.

Everyday Life and Support

Practical goals can include regular meals and sleep, reliable appointments, supportive relationships and alternatives to situations associated with use. People may benefit from planning how to respond to cravings without isolation or shame. Share information about prescribed and nonprescribed substances with clinicians.

Seek emergency help for severe chest pain, overheating, seizures, collapse or dangerous confusion. If someone is unresponsive or breathing slowly, suspect an overdose even when only stimulant use was expected; contact emergency services and use available naloxone according to its instructions.

History

Stimulants have been used in medicine as well as outside medical care, and changing patterns of availability have shaped public concern. Older records may separate cocaine abuse from cocaine dependence or use broad labels such as amphetamine dependence. DSM-5 brought abuse and dependence together as substance use disorders, while preserving distinctions between substance classes.

Modern guidelines emphasize effective behavioral treatment and medical care rather than a purely punitive response. The ASAM and AAAP guideline also addresses newer risks, including exposure to unexpected opioids in the drug supply. Historical descriptions that equate all stimulants, portray methamphetamine as simply a purer amphetamine or assume a particular social stereotype do not provide an accurate clinical account.

Sources and References

These sources distinguish the sustained use disorder from acute intoxication, withdrawal and induced psychiatric symptoms. The professional guideline explains the relative evidence for behavioral treatment and selected off-label medicines; individual treatment requires clinical assessment.

  1. Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders (2024)
  2. ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder
  3. What Is a Substance Use Disorder? (physician review 2024-04)
  4. Highlights of Changes from DSM-IV-TR to DSM-5 (2013)
  5. Opioid overdose
  6. Prescription Stimulant Medications
  7. ASAM/AAAP Clinical Practice Guideline on Stimulant Use Disorder
  8. NIMH: Understanding psychosis

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top